BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 5921488)

  • 1. Induced mammary carcinoma in the female rat as a drug evaluation system.
    Griswold DP; Skipper HE; Laster WR; Wilcox WS; Schabel FM
    Cancer Res; 1966 Oct; 26(10):2169-80. PubMed ID: 5921488
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on the hormone sensitivity of 7,12-dimethylbenz(alpha)anthracene-induced mammary tumors in the Sprague-Dawley rat.
    Griswold DP; Green CH
    Cancer Res; 1970 Mar; 30(3):819-26. PubMed ID: 5463906
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of 17-alpha-thioestradiol, 2 estradiol analogs, and 2 androgens on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Teller MN; Stock CC; Bowie M
    Cancer Res; 1966 Nov; 26(11):2329-33. PubMed ID: 5956637
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats.
    Heuson JC; Legros N; Heimann R
    Cancer Res; 1972 Feb; 32(2):233-8. PubMed ID: 5058184
    [No Abstract]   [Full Text] [Related]  

  • 5. [A method of testing the antitumor effectiveness of drugs on induced rat mammary gland cancer].
    Beskrovnyĭ AM
    Vopr Onkol; 1970; 16(8):62-6. PubMed ID: 5501884
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoplasms evoked in male Sprague-Dawley rat by pulse doses of 7,12-dimethylbenz(a)anthracene.
    Huggins CB; Grand L
    Cancer Res; 1966 Nov; 26(11):2255-8. PubMed ID: 5956630
    [No Abstract]   [Full Text] [Related]  

  • 7. Some biochemical characteristics of rodent and human mammary carcinomas.
    Hilf R; Goldenberg H; Bell C; Michel I; Orlando RA; Archer FL
    Enzymol Biol Clin (Basel); 1970; 11(1):162-76. PubMed ID: 4313121
    [No Abstract]   [Full Text] [Related]  

  • 8. Biologic characteristics and chemotherapy of 7,12-dimethylbenz[a]anthracene-induced tumors in rats.
    Teller MN; Stock CC; Stohr G; Merker PC; Kaufman RJ; Escher GC; Bowie M
    Cancer Res; 1966 Feb; 26(2):245-52. PubMed ID: 5903175
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathogenesis and hormonal prophylaxis of experimental dyshormonal mammary gland diseases].
    Dmitriev VN
    Biull Eksp Biol Med; 1970 Nov; 70(11):90-2. PubMed ID: 5495773
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of ergocornine and ergocryptine on growth of 7,12-dimethylbenzanthracene-induced mammary tumors in rats.
    Cassell EE; Meites J; Welsch CW
    Cancer Res; 1971 Jul; 31(7):1051-3. PubMed ID: 5560385
    [No Abstract]   [Full Text] [Related]  

  • 11. Criteria for evaluating hormones in the 7,12-dimethylbenz[a]-anthracene-induced mammary tumor-rat experimental chemotherapy system.
    Teller MN; Kaufman RJ; Stock CC; Bowie M
    Cancer Res; 1968 Feb; 28(2):368-71. PubMed ID: 5694312
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of mammary dysplasia and mammary carcinoma in neonatally androgenized female rats by 7,12-dimethylbenz[a]anthracene.
    Yoshida H; Kadota A; Fukunishi R; Matsumoto K
    J Natl Cancer Inst; 1980 May; 64(5):1105-12. PubMed ID: 6767873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction.
    Heuson JC; Legros N
    Cancer Res; 1972 Feb; 32(2):226-32. PubMed ID: 5058183
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of estrogens and endocrine ablation on duration of remission produced by ovariectomy or androgen treatment of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Teller MN; Kaufman RJ; Bowie M; Stock CC
    Cancer Res; 1969 Feb; 29(2):349-52. PubMed ID: 5765416
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormonal treatment of mammary tumors in rats induced by 3-methylcholanthrene (NSC-21970) and 7,12-dimethylbenz(alpha)anthracene (NSC-408823).
    Shimkin MB; Gropper L; Thatcher D; Gruenstein M
    Cancer Res; 1967 Nov; 27(11 Pt 2):1284-8. PubMed ID: 5630409
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced regression of DMBA-induced mammary cancers in rats by combination of ergocornine with ovariectomy or high doses of estrogen.
    Quadri SK; Kledzik GS; Meites J
    Cancer Res; 1974 Mar; 34(3):499-501. PubMed ID: 4812257
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of multiple pituitary homografts or progesterone on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Welsch CW; Clemens JA; Meites J
    J Natl Cancer Inst; 1968 Aug; 41(2):465-71. PubMed ID: 5671287
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of ovariectomy on experimental mammary carcinoma in the rat with portacaval shunt.
    O'Grady JF; Gruenstein M; Reichle FA
    Br J Surg; 1973 Apr; 60(4):317. PubMed ID: 4700266
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of ovariectomy on the protein and nucleic acid content of rat mammary tumours, induced by 9, 10-dimethyl-1,2-benzanthracene.
    Stevens L
    Br J Cancer; 1966 Sep; 20(3):546-9. PubMed ID: 5950879
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of progesterone, ovariectomy and adrenalectomy on mammary tumours induced by 7,12-dimethylbenz(a)anthracene in Sprague-Dawley rats.
    Jabara AG; Harcourt AG
    Pathology; 1971 Jul; 3(3):209-14. PubMed ID: 5115391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.